BRAULT VALERIE

No ORCID on file · 44 papers in corpus
2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…

2003
New 2,5-disubstituted benzimidazole derivatives, are gonadotropin releasing hormone antagonists useful e.g. for treating endometriosis, breast or prostate cancer or precocious puberty

The invention concerns novel benzimidazole derivatives of formula (I), wherein: A, Y, R1, R2, R3 and R4 represent diverse variable groups. Said products have a GnRH (Gonadotropin-Releasing Hormone) antagonist activity. The invention also co…